Veradermics (MANE) Share-based Compensation (2025 - 2026)

Veradermics' (MANE) quarterly Share-based Compensation came in at $213000.0 in Q1 2025.

Analysis

Veradermics (MANE) Share-based Compensation (2025 - 2026) Analysis & Trends

Veradermics (MANE) has 1 years of Share-based Compensation data on file, last reported at $213000.0 in Q1 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Share-based Compensation (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	108.10 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	243.00 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	120.00 Mn
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	277.20 Mn
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	137.41 Mn
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	86.63 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	41.25 Mn
10	Veradermics	3.96 Bn	3.96 Bn	-	3.52 Mn

Historic Data

Download Data